Pathological looping in the synucleinopathies: investigating the link between Parkinson’s disease and Gaucher disease

Pathological looping in the synucleinopathies: investigating the link between Parkinson’s disease and Gaucher disease

Bibliographic Details
Main Author:	Kerri J. Kinghorn
Format:	Article
Language:	English
Published:	The Company of Biologists 2011-11-01
Series:	Disease Models & Mechanisms
Online Access:	http://dmm.biologists.org/content/4/6/713

Similar Items

Gaucher Disease and the Synucleinopathies
by: Kathleen S. Hruska, et al.
Published: (2006-01-01)

Gaucher disease and the synucleinopathies: refining the relationship
by: Campbell Tessa N, et al.
Published: (2012-01-01)

The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease
by: Kerri J Kinghorn, et al.
Published: (2017-01-01)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
by: Emanuela Colla
Published: (2019-05-01)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
by: Akio Sekigawa, et al.
Published: (2015-05-01)

Glucocerebrosidase involvement in Parkinson Disease and other Synucleinopathies
by: Maria Rosario Almeida
Published: (2012-04-01)

Development of targeted therapies for Parkinson's disease and related synucleinopathies
by: Edmund Sybertz, et al.
Published: (2014-10-01)

The Link between Gaucher Disease and Parkinson’s Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism
by: Rossella Indellicato, et al.
Published: (2019-07-01)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
by: Irina Alecu, et al.
Published: (2019-04-01)

Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease
by: Caleb Pitcairn, et al.
Published: (2019-02-01)

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies
by: Maja Trošt, et al.
Published: (2019-11-01)

Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson’s Disease and Synucleinopathies
by: Cristine Betzer, et al.
Published: (2018-11-01)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
by: Hideya Mizuno, et al.
Published: (2011-01-01)

Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor
by: Kathryn M. Miller, et al.
Published: (2021-04-01)

Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants
by: Jing Yang, et al.
Published: (2021-03-01)

THE RELATIONSHIP OF PLAQUES, TANGLES, AND LEWY‐TYPE ALPHA‐SYNUCLEINOPATHY TO VISUAL HALLUCINATIONS IN PARKINSON’S DISEASE AND ALZHEIMER’S DISEASE
by: Morshed, Trisha
Published: (2015)

An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson’s Disease with α-Synucleinopathy
by: Soohyun Wi, et al.
Published: (2018-05-01)

Pathological implications of the interaction between neurexins and alpha-synuclein in synucleinopathies
by: Fallon, Aurélie
Published: (2021)

Gaucher Disease
by: Guilherme Henrique Hencklain Fonseca, et al.
Published: (2007-03-01)

Gaucher′s disease
by: Vijay Bohra, et al.
Published: (2011-01-01)

GAUCHER’S DISEASE
by: O. S. Gundobina, et al.
Published: (2013-11-01)

Immunotherapies in Huntington's disease and α-Synucleinopathies
by: Oluwaseun Fatoba, et al.
Published: (2020-02-01)

Association Between Progranulin and Gaucher Disease
by: Jinlong Jian, et al.
Published: (2016-09-01)

Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism
by: Benjamin McMahon, et al.
Published: (2016-01-01)

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
by: Masliah Eliezer, et al.
Published: (2011-08-01)

Parkinson’s disease in Gaucher disease patients: what’s changing in the counseling and management of patients and their relatives?
by: Maja Di Rocco, et al.
Published: (2020-09-01)

Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
by: Tae-Un Han, et al.
Published: (2020-05-01)

Cross-Reactivity and Sequence Homology Between Alpha-Synuclein and Food Products: A Step Further for Parkinson’s Disease Synucleinopathy
by: Aristo Vojdani, et al.
Published: (2021-05-01)

Interplay between Glucocerebrosidase 1 and Glucocerebrosidase 2 : potential implications for the pathogenesis of Gaucher and Parkinson's diseases
by: Burke, Derek Gerard
Published: (2017)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
by: Inês C. Brás, et al.
Published: (2021-02-01)

Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
by: Smriti Sinha, et al.
Published: (2021-09-01)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
by: Miguel Lemos, et al.
Published: (2020-09-01)

Evaluation of the frequency of non-motor symptoms of Parkinson’s disease in adult patients with Gaucher disease type 1
by: Matheus V. M. B. Wilke, et al.
Published: (2019-05-01)

<i>GBA</i>, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
by: Giulietta M. Riboldi, et al.
Published: (2019-04-01)

A Novel Microfluidic Cell Co-Culture Platform for the Study of the Molecular Mechanisms of Parkinson’s Disease and other Synucleinopathies
by: João Tiago Fernandes, et al.
Published: (2016-11-01)

Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
by: Kazunari Sekiyama, et al.
Published: (2012-01-01)

Dopamine Induced Post-Translational Modifications of α-Synuclein and the Role of Arsenic in the Development of Parkinson's Disease and Other Synucleinopathies
by: Cholanians, Aram B.
Published: (2016)

Lung Involvement in Gaucher Disease
by: Mahnaz Pejman Sani, et al.
Published: (2020-04-01)

Management algorithms for gaucher disease
by: Ayman Alhejazi, et al.
Published: (2020-01-01)

Enzyme replacement in Gaucher disease.
by: Ernest Beutler
Published: (2004-11-01)